ACB

Aurora Cannabis
NYSE

Real-time Quotes | Nasdaq Last Sale

5.20
+0.03
+0.58%
After Hours: 5.22 +0.02 +0.38% 19:42 09/24 EDT
OPEN
5.08
PREV CLOSE
5.17
HIGH
5.37
LOW
4.780
VOLUME
14.63M
TURNOVER
--
52 WEEK HIGH
60.84
52 WEEK LOW
4.780
MARKET CAP
572.46M
P/E (TTM)
-0.0033
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Can This Pot Stock Pullback Equal Gains for Investors?
Is Now The Time To Buy Marijuana Stocks? 
Benzinga · 8h ago
State ballot measures to legalize cannabis could add $9 billion to US marijuana market
Arizona, Mississippi, Montana, New Jersey and South Dakota are letting voters decide on legal cannabis this year. That could give a big boost to the size of the legal US cannabis market.
Yahoo Finance · 19h ago
Are Marijuana Stocks Buys As Analyst Pleads 'Stop Growing So Much Weed'?
Investor's Business Daily · 1d ago
Are Marijuana Stocks Buys As Analyst Pleads 'Stop Growing So Much Weed'?
Investor's Business Daily · 1d ago
Aurora Falls 30%. ‘Please Stop Growing So Much Weed.’
“Aurora grows more stuff that people don’t want than they grow stuff people want,” analyst Bill Kirk wrote.
marketwatch.com · 1d ago
Aurora Cannabis Stock Plunged 30% Because It Is ‘Growing So Much Weed’
“Aurora grows more stuff that people don’t want than they grow stuff people want,” analyst Bill Kirk wrote.
Barrons.com · 1d ago
Aurora Cannabis Earnings: Lets Shed Some Light on That Pullback
On Monday, shares of Aurora Cannabis (ACB) surged by 16% following an analyst upgrade and in anticipation of what investors hoped would be a positive earnings report to mark a turnaround from recent travails. However, the results followed what is by now a familiar story and on Tuesday, Aurora handed
TipRanks · 1d ago
Aurora Sinks to 4-Year Low, Told to ‘Stop Growing So Much Weed’
(Bloomberg) -- Aurora Cannabis Inc. shares tumbled to the lowest price in four years after its fourth-quarter results prompted an MKM Partners analyst to tell the company, “Please stop growing so much weed.”Shares fell as much as 25% in Toronto trading, the biggest drop in six months, to the lowest level
Bloomberg · 1d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ACB. Analyze the recent business situations of Aurora Cannabis through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ACB stock price target is 18.86 with a high estimate of 35.50 and a low estimate of 0.0000.
EPS
Institutional Holdings
Institutions: 11
Institutional Holdings: 63.74K
% Owned: 0.06%
Shares Outstanding: 110.09M
TypeInstitutionsShares
Increased
0
0
New
2
23.18K
Decreased
1
100
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.83%
Pharmaceuticals & Medical Research
-0.82%
Key Executives
Chairman/Executive Director
Michael Singer
Chief Executive Officer
Miguel Martin
Chief Executive Officer/Director
Terry Booth
Chief Financial Officer
Glen Ibbott
Chief Operating Officer
Allan Cleiren
Chief Human Resource Officer
Debra Wilson
Senior Vice President
Rick Savone
Chief Information Officer
Darryl Vleeming
Other
Neil Belot
Other
Jonathan Page
Other
Cam Battley
Other
Andrea Paine
Secretary
Jillian Swainson
Lead Director/Independent Director
Ronald Funk
Independent Director
Margaret Atkins
Independent Director
Norma Beauchamp
Independent Director
Michael Detlefsen
Independent Director
Jason Dyck
Independent Director
Lance Friedmann
Independent Director
Adam Szweras
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ACB
Aurora Cannabis Inc is a Canada-based medical cannabis company. The Company’s principal strategic business lines are focused on the production, distribution and sale of cannabis in Canada and internationally. The Company is focused on offering its cannabis products to global medical cannabis market, consumer use cannabis market and global hemp-derived cannabidiol (CBD) markets. The Company offers varieties of cannabis infused products under various brands that includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and ROAR Sports. Its products portfolio includes dried cannabis, cannabis oil, soft-gels, oral dissolve strips, edibles, vaporizers and cannabis infused chocolates.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Aurora Cannabis Inc stock information, including NYSE:ACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACB stock methods without spending real money on the virtual paper trading platform.